NLS Pharmaceutics AG
NASDAQ:NLSP
4.15 (USD) • At close November 7, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
2024 Q2 | 2023 Q4 | 2023 Q2 | 2022 Q4 | 2022 Q2 | 2021 Q4 | 2021 Q2 | 2020 Q4 | 2020 Q2 | 2019 Q4 | 2019 Q2 | 2018 Q4 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets: | ||||||||||||
Current Assets: | ||||||||||||
Cash & Cash Equivalents
| 0.553 | 0.898 | 1.651 | 8.948 | 1.354 | 5.431 | 7.092 | 0.094 | 0.145 | 0.22 | 1.225 | 0.007 |
Short Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash and Short Term Investments
| 0.553 | 0.898 | 1.651 | 8.948 | 1.354 | 5.431 | 7.092 | 0.094 | 0.145 | 0.22 | 1.225 | 0.007 |
Net Receivables
| 0.032 | 0.011 | 0.064 | 0.041 | 0.06 | 0.039 | 0.043 | 0.061 | 0.013 | 0.075 | 0.01 | 0 |
Inventory
| 0.297 | 0 | -0.064 | -0.041 | -0.06 | -0.039 | -0.043 | -0.061 | 0 | 0 | 0 | 0 |
Other Current Assets
| 0.311 | 0.915 | 0.594 | 0.298 | 0.668 | 0.292 | 1.149 | 0.103 | 0.063 | 0.086 | 0.084 | 0.083 |
Total Current Assets
| 1.192 | 1.823 | 2.245 | 9.246 | 2.023 | 5.723 | 8.241 | 0.197 | 0.221 | 0.382 | 1.318 | 0.09 |
Non-Current Assets: | ||||||||||||
Property, Plant & Equipment, Net
| 0.001 | 0.007 | 0.012 | 0.018 | 0.024 | 0.03 | 0.028 | 0 | 0 | 0 | 0 | 0 |
Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Long Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.068 | 0.056 | 0.054 | 0.055 | 0 |
Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets
| -0 | 0.017 | 0.013 | 0.012 | 0.012 | 0.012 | -0 | 0.947 | 0.363 | 0.26 | 0 | 0.055 |
Total Non-Current Assets
| 0.001 | 0.024 | 0.025 | 0.03 | 0.036 | 0.042 | 0.028 | 1.015 | 0.419 | 0.315 | 0.055 | 0.055 |
Total Assets
| 1.193 | 1.847 | 2.27 | 9.277 | 2.058 | 5.765 | 8.269 | 1.212 | 0.64 | 0.696 | 1.374 | 0.146 |
Liabilities & Equity: | ||||||||||||
Current Liabilities: | ||||||||||||
Account Payables
| 4.584 | 4.634 | 3.113 | 2.373 | 2.522 | 1.737 | 0.527 | 4.006 | 2.756 | 2.509 | 1.854 | 1.131 |
Short Term Debt
| 1.714 | 1.634 | 0 | 0 | 0.354 | -2,499.969 | 0 | 1.771 | 0.793 | 0.69 | 0.684 | 0.708 |
Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Revenue
| 1.142 | 0 | 0 | 0 | 0 | 2,499.969 | 0 | 2,499.969 | 0 | -0 | 0 | 0 |
Other Current Liabilities
| 0.278 | 1.652 | 0.779 | 0.986 | 0.535 | 0.666 | 0.666 | -2,498.543 | 1.172 | 0.836 | 0.382 | 0.576 |
Total Current Liabilities
| 7.718 | 7.92 | 3.892 | 3.36 | 3.411 | 2.403 | 1.193 | 7.204 | 4.721 | 4.035 | 2.92 | 2.415 |
Non-Current Liabilities: | ||||||||||||
Long Term Debt
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.313 | 0.575 | 0.152 | 0 | 6.386 |
Deferred Revenue Non-Current
| 2.5 | 2.5 | 2.5 | 2.5 | 2.5 | 2.5 | 2.5 | 2.5 | 2.5 | 2.5 | 2.5 | 0 |
Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0 | 0 | 0 | 0 |
Other Non-Current Liabilities
| 0.244 | 0.261 | 0.165 | 0.136 | 0.189 | 0.319 | 0.327 | 0.178 | 0.178 | 0.18 | 0.151 | 0.159 |
Total Non-Current Liabilities
| 2.744 | 2.761 | 2.665 | 2.636 | 2.689 | 2.819 | 2.827 | 2.992 | 3.253 | 2.832 | 2.651 | 6.545 |
Total Liabilities
| 10.462 | 10.68 | 6.557 | 5.996 | 6.1 | 5.222 | 4.02 | 10.196 | 7.974 | 6.867 | 5.571 | 8.959 |
Equity: | ||||||||||||
Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Common Stock
| 0.809 | 0.733 | 0.733 | 0.669 | 0.411 | 0.344 | 0.26 | 0.145 | 0.145 | 0.145 | 0.145 | 0.134 |
Retained Earnings
| -72.409 | -70.373 | -65.814 | -58.201 | -50.347 | -41.706 | -34.363 | -29.76 | -28.13 | -26.898 | -24.866 | -21.451 |
Accumulated Other Comprehensive Income/Loss
| 0.004 | -0.158 | -0.066 | -0.051 | -0.033 | -0.152 | -0.18 | -0.019 | -0.019 | -0.019 | -0.011 | -0.011 |
Other Total Stockholders Equity
| 62.328 | 60.965 | 60.86 | 60.865 | 45.927 | 42.055 | 38.532 | 20.65 | 20.67 | 20.601 | 20.535 | 12.515 |
Total Shareholders Equity
| -9.268 | -8.834 | -4.287 | 3.281 | -4.041 | 0.542 | 4.249 | -8.984 | -7.334 | -6.171 | -4.197 | -8.814 |
Total Equity
| -9.268 | -8.834 | -4.287 | 3.281 | -4.041 | 0.542 | 4.249 | -8.984 | -7.334 | -6.171 | -4.197 | -8.814 |
Total Liabilities & Shareholders Equity
| 1.193 | 1.847 | 2.27 | 9.277 | 2.058 | 5.765 | 8.269 | 1.212 | 0.64 | 0.696 | 1.374 | 0.146 |